ROGAINE (FOR WOMEN) Drug Patent Profile
✉ Email this page to a colleague
When do Rogaine (for Women) patents expire, and what generic alternatives are available?
Rogaine (for Women) is a drug marketed by Johnson And Johnson and is included in one NDA.
The generic ingredient in ROGAINE (FOR WOMEN) is minoxidil. There are eight drug master file entries for this compound. One hundred and five suppliers are listed for this compound. Additional details are available on the minoxidil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Rogaine (for Women)
A generic version of ROGAINE (FOR WOMEN) was approved as minoxidil by WATSON LABS on March 3rd, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ROGAINE (FOR WOMEN)?
- What are the global sales for ROGAINE (FOR WOMEN)?
- What is Average Wholesale Price for ROGAINE (FOR WOMEN)?
Summary for ROGAINE (FOR WOMEN)
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 131 |
| Clinical Trials: | 6 |
| DailyMed Link: | ROGAINE (FOR WOMEN) at DailyMed |
-patent-expirations.png "ROGAINE (FOR WOMEN) drug patent expirations")
Recent Clinical Trials for ROGAINE (FOR WOMEN)
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ohio State University Comprehensive Cancer Center | Early Phase 1 |
| Cures Within Reach | Phase 2 |
| Loyola University | Phase 2 |
Pharmacology for ROGAINE (FOR WOMEN)
| Drug Class | Arteriolar Vasodilator |
| Physiological Effect | Arteriolar Vasodilation |
US Patents and Regulatory Information for ROGAINE (FOR WOMEN)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Johnson And Johnson | ROGAINE (FOR WOMEN) | minoxidil | SOLUTION;TOPICAL | 019501-003 | Feb 9, 1996 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
